BBA
PGNX
Baker Bros. Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-979,016
| Closed | -$7.87M | – | 122 |
|
2018
Q2 | $7.87M | Sell |
979,016
-1,327,168
| -58% | -$10.7M | 0.06% | 60 |
|
2018
Q1 | $17.2M | Sell |
2,306,184
-844,624
| -27% | -$6.3M | 0.15% | 45 |
|
2017
Q4 | $18.7M | Hold |
3,150,808
| – | – | 0.16% | 46 |
|
2017
Q3 | $23.2M | Hold |
3,150,808
| – | – | 0.19% | 35 |
|
2017
Q2 | $21.4M | Hold |
3,150,808
| – | – | 0.19% | 29 |
|
2017
Q1 | $29.7M | Hold |
3,150,808
| – | – | 0.24% | 28 |
|
2016
Q4 | $27.2M | Sell |
3,150,808
-500,000
| -14% | -$4.32M | 0.27% | 28 |
|
2016
Q3 | $23.1M | Sell |
3,650,808
-319,442
| -8% | -$2.02M | 0.21% | 28 |
|
2016
Q2 | $16.8M | Sell |
3,970,250
-380,558
| -9% | -$1.61M | 0.18% | 36 |
|
2016
Q1 | $19M | Hold |
4,350,808
| – | – | 0.2% | 36 |
|
2015
Q4 | $26.7M | Hold |
4,350,808
| – | – | 0.22% | 34 |
|
2015
Q3 | $24.9M | Hold |
4,350,808
| – | – | 0.23% | 32 |
|
2015
Q2 | $32.5M | Hold |
4,350,808
| – | – | 0.28% | 36 |
|
2015
Q1 | $26M | Sell |
4,350,808
-98,989
| -2% | -$592K | 0.22% | 36 |
|
2014
Q4 | $33.6M | Hold |
4,449,797
| – | – | 0.34% | 29 |
|
2014
Q3 | $23.1M | Hold |
4,449,797
| – | – | 0.29% | 32 |
|
2014
Q2 | $19.2M | Hold |
4,449,797
| – | – | 0.23% | 39 |
|
2014
Q1 | $18.2M | Buy |
4,449,797
+249,797
| +6% | +$1.02M | 0.23% | 40 |
|
2013
Q4 | $22.4M | Hold |
4,200,000
| – | – | 0.32% | 34 |
|
2013
Q3 | $21.1M | Hold |
4,200,000
| – | – | 0.3% | 31 |
|
2013
Q2 | $18.7M | Buy |
+4,200,000
| New | +$18.7M | 0.37% | 28 |
|